ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AX12 | G | Gabapentin - 300mg | 8704 | 85216/1 | GABAPENTINE ARROW GENERIQUES | 300mg | 90 | Capsule | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 1,342,499 L.L | 23.08 | A2 | Arrow Génériques | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AX12 | G | Gabapentin - 300mg | 6635 | 167485/10 | APO-GABAPENTIN | 300mg | 100 | Capsule | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 2,527,768 L.L | 23.08 | B | Apotex Inc | Canada | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 300mg | 9799 | 122718/1 | GABAMOX | 300mg | 60 | Capsule, hard | Oral | New Allpharma | Farmalabor Produtos Farmaceuticos SA | Portugal | 1,108,670 L.L | 23.08 | A2 | Penta Farma | Portugal | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 300mg | 6311 | 24970/07 | GABANET 300 | 300mg | 48 | Capsule | Oral | C. Catafago & Co | The Jordanian Pharmaceutical Manufacturing Co. (JPM) | Jordan | 1,380,126 L.L | 23.08 | A2 | The Jordanian Pharmaceutical Manufacturing & Co Ltd | Jordan | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 300mg | 6622 | 24989/07 | GABATREX | 300mg | 50 | Capsule | Oral | Abela Frères S.A.L. | Hikma Pharmaceuticals | Jordan | 1,585,734 L.L | 23.08 | B | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 300mg | 6570 | 218590/10 | NEUROPLEX | 300mg | 50 | Capsule | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 1,107,326 L.L | 23.08 | A2 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 300mg | 6324 | 167454/10 | PMS-GABAPENTIN | 300mg | 50 | Capsule | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 869,466 L.L | 23.08 | A2 | Pharmascience Inc | Canada | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 300mg | 6689 | 167644/10 | VOLAR | 300mg | 30 | Capsule | Oral | Sadco | Dar Al Dawa | Jordan | 1,100,607 L.L | 23.08 | A2 | Dar Al Dawa | Jordan | 2/5/2024 | 0 |